Sunday, November 3, 2024
HomeTagsRobert O. Dillman

Robert O. Dillman

AIVITA Biomedical Announces Publication of Phase 1 and Phase 2 Trial Results of its COVID-19 Vaccine Candidate

AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today announced the publication of safety and efficacy results from Phase 1 and...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics